Elixi, Author at Elixi International - Page 11 of 13

15 August 2019

Baqsimi nasal powder ( glucagon), first treatment for severe hypoglycemia that can be administered without an injection

0 Comments4 Minutes

9 August 2019

Vitrakvi (larotrectinib), first ‘histology-independent’ treatment for solid tumours with a specific gene mutation

0 Comments4 Minutes

17 July 2019

Victoza, liraglutide, new treatment for children with type 2 diabetes

0 Comments4 Minutes

16 July 2019

Dupixent (dupilumab), first treatment for chronic rhinosinusitis with nasal polyps

0 Comments3 Minutes

10 July 2019

FDA approves Soliris (eculizumab), first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system

0 Comments5 Minutes

10 July 2019

FDA approves Xpovio (selinexor), new treatment for refractory multiple myeloma

0 Comments5 Minutes

31 May 2019

Piqray (alpelisib), first PI3K inhibitor for breast cancer

0 Comments6 Minutes

26 May 2019

Zolgensma (onasemnogene abeparvovec-xioi), innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality

0 Comments7 Minutes

18 May 2019

FDA approves Fragmin (dalteparin sodium) first anticoagulant for pediatric patients to treat potentially life-threatening blood clots

0 Comments4 Minutes

7 May 2019

Dengvaxia, the first vaccine approved by FDA for the prevention of dengue disease caused by all dengue virus serotypes

0 Comments6 Minutes